Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352172 | 12635217 | 2 | F | 2009 | 20160817 | 20160809 | 20160823 | EXP | PHHY2016BR108745 | NOVARTIS | 50.32 | YR | F | Y | 90.00000 | KG | 20160823 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352172 | 12635217 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF (VALSARTAN 160 MG), QD | U | 21283 | 1 | DF | TABLET | QD | |||||
| 126352172 | 12635217 | 2 | SS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF (VALSARTAN 320 MG), QD | U | 21283 | 1 | DF | TABLET | QD | |||||
| 126352172 | 12635217 | 3 | SS | DIOVAN AMLO FIX | AMLODIPINEVALSARTAN | 1 | Oral | 1 DF (VALSARTAN 320 MG/ AMLODIPINE 5 MG), QD | SC524 | 0 | 1 | DF | TABLET | QD | |||||
| 126352172 | 12635217 | 4 | C | SELOZOK | METOPROLOL SUCCINATE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | TABLET | QD | ||||||
| 126352172 | 12635217 | 5 | C | SINVASTATINA | SIMVASTATIN | 1 | Oral | 40 MG, BID | 0 | 40 | MG | BID | |||||||
| 126352172 | 12635217 | 6 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, BID | 0 | 20 | MG | BID | |||||||
| 126352172 | 12635217 | 7 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126352172 | 12635217 | 8 | C | BURINAX | BUMETANIDE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 126352172 | 12635217 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126352172 | 12635217 | 1 | Hypertension |
| 126352172 | 12635217 | 3 | Hypertension |
| 126352172 | 12635217 | 4 | Chest pain |
| 126352172 | 12635217 | 5 | Blood cholesterol increased |
| 126352172 | 12635217 | 6 | Depression |
| 126352172 | 12635217 | 7 | Anxiety |
| 126352172 | 12635217 | 8 | Diuretic therapy |
| 126352172 | 12635217 | 9 | Blood disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126352172 | 12635217 | HO |
| 126352172 | 12635217 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126352172 | 12635217 | Appendicitis | |
| 126352172 | 12635217 | Blood pressure fluctuation | |
| 126352172 | 12635217 | Dizziness | |
| 126352172 | 12635217 | Haemorrhage | |
| 126352172 | 12635217 | Headache | |
| 126352172 | 12635217 | Insomnia | |
| 126352172 | 12635217 | Malaise | |
| 126352172 | 12635217 | Myocardial infarction | |
| 126352172 | 12635217 | Nausea | |
| 126352172 | 12635217 | Pterygium |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126352172 | 12635217 | 1 | 2006 | 2006 | 0 | |
| 126352172 | 12635217 | 2 | 2006 | 201604 | 0 | |
| 126352172 | 12635217 | 3 | 201604 | 0 | ||
| 126352172 | 12635217 | 4 | 201605 | 0 | ||
| 126352172 | 12635217 | 5 | 201605 | 0 | ||
| 126352172 | 12635217 | 6 | 2016 | 0 | ||
| 126352172 | 12635217 | 9 | 201605 | 0 |